The UNC Health logo falls under strict regulation. We ask that you please do not attempt to download, save, or otherwise use the logo without written consent from the UNC Health administration. Please contact our media team if you have any questions.
As prostate cancer continues to affect men across North Carolina, advances in detection and targeted treatment are changing how physicians approach localized and metastatic forms of the disease.
The international research effort created hundreds of patient-derived cancer models that closely reflect the molecular features of patients’ original tumors.
UNC Lineberger’s Advanced Cellular Therapeutics Facility is helping to improve personalized CAR T-cell therapy for patients in North Carolina and around the world.
The Mathers Foundation, a highly selective national funder of innovative basic biomedical research, is supporting Thaxton’s work on a discovery that has the potential to transform human health.
Researchers will develop and implement new strategies to address common barriers to care and reach patients due for cancer screenings for breast, colorectal, lung, and/or cervical cancers.
Backed by results from the OPTIMA trial, the Prosigna Breast Risk of Recurrence (ROR) test offers a new way to personalize treatment and reduce unnecessary chemotherapy for patients with breast…